EU Inspectors Find More Than 1,000 Clinical Trial Deficiencies
Executive Summary
The number of deficiencies found by EU GCP inspectors rose to 1,033 in 2016, compared with 912 in 2015, although the number of problematic findings considered “critical” was down slightly. Meanwhile, Japan has asked to join the EMA/FDA initiative on GCP inspections.